D-854-2013 Class III Terminated

Recalled by Sandoz Incorporated — Broomfield, CO

FDA drug recall D-854-2013 was initiated by Sandoz Incorporated on Aug 7, 2013 and is designated Class III. Reason for recall: Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive… The recall status is terminated (terminated Jul 7, 2014). Affected quantity: 8, 681 unit cartons.

Recall details

Product Type
Drugs
Report Date
Aug 14, 2013
Initiation Date
Aug 7, 2013
Termination Date
Jul 7, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8, 681 unit cartons

Product description

Introvale (levonorgestrel and ethinyl estradiol) tablets, USP, 0.15 mg/0.03 mg, packaged in 91 day regimen per unit carton, 3 Unit Cartons x 91 tablets per box, Rx only, Manufactured by Laboratorios Leon Farma S.A., Spain for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5584-36

Reason for recall

Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive placebo tablets incorrectly placed in Week 9, and active tablets placed in Week 13 on the blister card

Distribution pattern

Nationwide

Code information

Lots: LF01643C, LF01644C, Exp 7/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-854-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-854-2013. Report a data issue: hello@regdatalab.com.